These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19918922)

  • 1. A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D(3) in breast cancer patients with bone metastases.
    Amir E; Simmons CE; Freedman OC; Dranitsaris G; Cole DE; Vieth R; Ooi WS; Clemons M
    Cancer; 2010 Jan; 116(2):284-91. PubMed ID: 19918922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
    Clemons MJ; Dranitsaris G; Ooi WS; Yogendran G; Sukovic T; Wong BY; Verma S; Pritchard KI; Trudeau M; Cole DE
    J Clin Oncol; 2006 Oct; 24(30):4895-900. PubMed ID: 17001071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation.
    Jean G; Souberbielle JC; Chazot C
    Nephrol Dial Transplant; 2009 Dec; 24(12):3799-805. PubMed ID: 19622574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium and vitamin D supplementation during bisphosphonate administration may increase osteoclastic activity in patients with bone metastasis.
    Altundag O; Altundag K; Selim Silay Y; Gunduz M; Demircan K; Gullu I
    Med Hypotheses; 2004; 63(6):1010-3. PubMed ID: 15504568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of vitamin D deficiency in breast cancer patients on bisphosphonates.
    Wang-Gillam A; Miles DA; Hutchins LF
    Oncologist; 2008 Jul; 13(7):821-7. PubMed ID: 18614589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered calcium metabolism in patients on long-term bisphosphonate therapy for metastatic breast cancer.
    Simmons C; Amir E; Dranitsaris G; Clemons M; Wong B; Veith R; Cole DE
    Anticancer Res; 2009 Jul; 29(7):2707-11. PubMed ID: 19596950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I dose-ranging trial of monthly infusions of zoledronic acid for the treatment of osteolytic bone metastases.
    Berenson JR; Vescio RA; Rosen LS; VonTeichert JM; Woo M; Swift R; Savage A; Givant E; Hupkes M; Harvey H; Lipton A
    Clin Cancer Res; 2001 Mar; 7(3):478-85. PubMed ID: 11297237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and pain palliation of zoledronic acid in patients with breast cancer, prostate cancer, or multiple myeloma who previously received bisphosphonate therapy.
    Vogel CL; Yanagihara RH; Wood AJ; Schnell FM; Henderson C; Kaplan BH; Purdy MH; Orlowski R; Decker JL; Lacerna L; Hohneker JA
    Oncologist; 2004; 9(6):687-95. PubMed ID: 15561812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease.
    Brown JE; McCloskey EV; Dewar JA; Body JJ; Cameron DA; Harnett AN; Ruutu M; Purohit OP; Tähtelä R; Coleman RE
    Calcif Tissue Int; 2007 Nov; 81(5):341-51. PubMed ID: 17874331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].
    Wojnar J; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
    Przegl Lek; 2007; 64(9):552-8. PubMed ID: 18510075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone.
    Zheng Y; Zhou H; Modzelewski JR; Kalak R; Blair JM; Seibel MJ; Dunstan CR
    Cancer Res; 2007 Oct; 67(19):9542-8. PubMed ID: 17909065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of bone remodelling markers in patients with bone metastases treated with zoledronic acid.
    Pectasides D; Nikolaou M; Farmakis D; Kanakis I; Gaglia A; Kountourakis P; Karamanos NK; Economopoulos T; Raptis SA
    Anticancer Res; 2005; 25(2B):1457-63. PubMed ID: 15865105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients.
    Tokmak F; Quack I; Schieren G; Sellin L; Rattensperger D; Holland-Letz T; Weiner SM; Rump LC
    Nephrol Dial Transplant; 2008 Dec; 23(12):4016-20. PubMed ID: 18593741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of daily regimen calcium and vitamin D supplementation on parathyroid hormone secretion.
    Reginster JY; Zegels B; Lejeune E; Micheletti MC; Kvsaz A; Seidel L; Sarlet N
    Calcif Tissue Int; 2002 Feb; 70(2):78-82. PubMed ID: 11870412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease.
    Oksa A; Spustová V; Krivosíková Z; Gazdíková K; Fedelesová V; Lajdová I; Stefíková K; Bernasovská G; Zilinská Z; Dzúrik R
    Kidney Blood Press Res; 2008; 31(5):322-9. PubMed ID: 18802363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone: a multicenter clinical trial.
    Cartenì G; Bordonaro R; Giotta F; Lorusso V; Scalone S; Vinaccia V; Rondena R; Amadori D
    Oncologist; 2006; 11(7):841-8. PubMed ID: 16880243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D-deficient HIV-1-infected patients.
    van den Bout-van den Beukel CJ; van den Bos M; Oyen WJ; Hermus AR; Sweep FC; Tack CJ; Bosch ME; Burger DM; Koopmans PP; van der Ven AJ
    HIV Med; 2008 Oct; 9(9):771-9. PubMed ID: 18754805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percent true calcium absorption, mineral metabolism, and bone mass in children with arthritis: effect of supplementation with vitamin D3 and calcium.
    Hillman LS; Cassidy JT; Chanetsa F; Hewett JE; Higgins BJ; Robertson JD
    Arthritis Rheum; 2008 Oct; 58(10):3255-63. PubMed ID: 18821668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.